 |
Danzig Carl J; Dinah Christiana; Ghanchi Faruque; Hattenbach Lars-Olof; Khanani Arshad M; Lai Timothy Y Y; Shimura Masahiko; Abreu Francis; Arrisi Pablo; Liu Ying; Paris Liliana P; Retiere Anne-Cecile; Willis Jeffrey R; Schlottmann Patricio G; Tóth-Molnár Edit:
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion. 72-Week Results from the BALATON and COMINO Trials.
OPHTHALMOLOGY RETINA, 9 (9).
pp. 848-859.
ISSN 2468-6530
(2025)
Wykoff Charles C.; Abreu Francis; Adamis Anthony P.; Basu Karen; Eichenbaum David A.; Haskova Zdenka; Lin Hugh; Loewenstein Anat; Mohan Shaun; Pearce Ian A.; Sakamoto Taiji; Schlottmann Patricio G.; Papp András; Tóth-Molnár Edit; Kollaborációs szervezet: YOSEMITE and RHINE Investigators:
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
LANCET, 399 (10326).
pp. 741-755.
ISSN 0140-6736
(2022)
![[Fel]](/style/images/multi_up.png)
Vissza
